Teppema Luc J, Romberg Raymonda R, Dahan Albert
Department of Anesthesiology, Leiden University Medical Center, PO Box 9604, 2300 RC Leiden, The Netherlands. l.j.s.m.teppema@;umc.nl
Anesthesiology. 2005 Apr;102(4):747-53. doi: 10.1097/00000542-200504000-00009.
In subanesthetic concentrations, volatile anesthetics reduce the acute hypoxic response (AHR), presumably by a direct action on the carotid bodies but by an unknown molecular mechanism. To examine a possible involvement of reactive oxygen species or changes in redox state in this inhibiting effect, the authors studied the effect of antioxidants on the isoflurane-induced reduction of the AHR in humans.
In 10 volunteers, the authors studied the effect of antioxidants (intravenous ascorbic acid and oral alpha-tocopherol) on the reduction by isoflurane (0.12% end-tidal concentration) of the AHR on a 3-min isocapnic hypoxic stimulus (hemoglobin oxygen saturation 86 +/- 4%). All subjects participated in three separate sessions in which the effects of the antioxidants (session 1), placebo (session 2), and sham isoflurane plus antioxidants (session 3) were tested on the (sham) isoflurane-induced effect on the AHR.
Isoflurane reduced the acute hypoxic response from 0.82 +/- 0.41 l . min . % to 0.49 +/- 0.23 l . min . % and from 0.89 +/- 0.43 l . min . % to 0.48 +/- 0.28 l . min . % in sessions 1 and 2, respectively (mean +/- SD; P < 0.05 vs. control). This reduction of the AHR was completely reversed by antioxidants (AHR = 0.76 +/- 0.39 l . min . %; not significantly different from control, session 1) but not by placebo in session 2 (AHR = 0.50 +/- 0.30 l . min . %; P < 005 vs. control). Sham isoflurane or antioxidants per se had no effect on the hypoxic response.
The data indicate that isoflurane may depress the AHR by influencing the redox state of oxygen-sensing elements in the carotid bodies. This finding may have clinical implications for patients who are prone to recurrent hypoxic episodes, e.g., due to upper airway obstruction, in the postoperative period when low-dose isoflurane may persist in the body for some time.
在亚麻醉浓度下,挥发性麻醉药可降低急性低氧反应(AHR),推测是通过直接作用于颈动脉体,但分子机制尚不清楚。为了研究活性氧或氧化还原状态变化在这种抑制作用中可能的参与情况,作者研究了抗氧化剂对异氟烷诱导的人体AHR降低的影响。
在10名志愿者中,作者研究了抗氧化剂(静脉注射维生素C和口服α-生育酚)对异氟烷(呼气末浓度0.12%)在3分钟等碳酸低氧刺激(血红蛋白氧饱和度86±4%)时降低AHR的影响。所有受试者参加三个独立的实验阶段,分别测试抗氧化剂(实验阶段1)、安慰剂(实验阶段2)和假异氟烷加抗氧化剂(实验阶段3)对(假)异氟烷诱导的AHR影响。
在实验阶段1和2中,异氟烷分别将急性低氧反应从0.82±0.41升·分钟·%降至0.49±0.23升·分钟·%,以及从0.89±0.43升·分钟·%降至0.48±0.28升·分钟·%(平均值±标准差;与对照组相比,P<0.05)。抗氧化剂可完全逆转AHR的这种降低(AHR = 0.76±0.39升·分钟·%;与实验阶段1的对照组无显著差异),但实验阶段2中的安慰剂则不能(AHR = 0.50±0.30升·分钟·%;与对照组相比,P<0.05)。假异氟烷或抗氧化剂本身对低氧反应无影响。
数据表明,异氟烷可能通过影响颈动脉体中氧传感元件的氧化还原状态来抑制AHR。这一发现可能对术后易发生反复低氧发作的患者具有临床意义,例如由于上呼吸道梗阻,此时低剂量异氟烷可能在体内持续一段时间。